Back to Network
7
Shared Docs
7
Same-Page
7 / 7
Mentions
Document Mentions (7 shared documents)
2 mentions1 same-page
Page ?Same page
ltiples of the revenue generated by stand alone KCG/Knight doing "similar or less" volume. The quarter I refer to: 1Q2014. My "March 2014 letter to McKessy". Where ANOTHER massive ibcrease in OTCM share volumes occurred. AND where an immediate investigation SHOULD have been triggered. It did not. In fac
o was CEO of Stem Cell Therapy until 2008 https://www.sec.gov/Archives/edgar/data/1360479/000136086508000043/sciil0ksbmarch312008.txt In 2009/2010, Stem Cell Therapy did a "financing" with Prolific Bag Man Terren Peizer: Socius Form S-1 (sec.gov) EFTA00070379 Rule 424b3 Filing (sec gov) The SEC revoked the St
2 mentions1 same-page
Page ?Same page
ltiples of the revenue generated by stand alone KCG/Knight doing "similar or less" volume. The quarter I refer to: 1Q2014. My "March 2014 letter to McKessy". Where ANOTHER massive ibcrease in OTCM share volumes occurred. AND where an immediate investigation SHOULD have been triggered. It did not. In fac
em Cell Therapy until 2008 EFTA00093879 https://www.sec.gov/Archives/edgar/data/1360479/000136086508000043/sciilOksbmarch312008.txt In 2009/2010, Stem Cell Therapy did a "financing" with Prolific Bag Man Terren Peizer: Socius Form S-1 (sec.gov) Rule 424b3 Filing (sec gov) The SEC revoked the Stem Cell Therapy
2 mentions1 same-page
Page ?Same page
ltiples of the revenue generated by stand alone KCG/Knight doing "similar or less" volume. The quarter I refer to: 1Q2014. My "March 2014 letter to McKessy". Where ANOTHER massive ibcrease in OTCM share volumes occurred. AND where an immediate investigation SHOULD have been triggered. It did not. In fac
o was CEO of Stem Cell Therapy until 2008 https://www.sec.gov/Archives/edgar/data/1360479/000136086508000043/sciil0ksbmarch312008.txt In 2009/2010, Stem Cell Therapy did a "financing" with Prolific Bag Man Terren Peizer: Socius Form S-1 (sec.gov) Rule 424b3 Filing (sec.gov) The SEC revoked the Stem Cell Therapy
Sponsored
2 mentions1 same-page
Page ?Same page
ltiples of the revenue generated by stand alone KCG/Knight doing "similar or less" volume. The quarter I refer to: 1Q2014. My "March 2014 letter to McKessy". Where ANOTHER massive ibcrease in OTCM share volumes occurred. AND where an immediate investigation SHOULD have been triggered. It did not. In fac
em Cell Therapy until 2008 EFTA00093715 https://www.sec.gov/Archives/edgar/data/1360479/000136086508000043/sciilOksbmarch312008.txt In 2009/2010, Stem Cell Therapy did a "financing" with Prolific Bag Man Terren Peizer: Socius Form S-1 (sec.gov) Rule 424b3 Filing (sec.gov) The SEC revoked the Stem Cell Therapy
2 mentions1 same-page
Page ?Same page
revenue generated by stand alone KCG/Knight doing "similar or less" volume. The quarter I refer to: 1Q2014. EFTA00070049 My "March 2014 letter to McKessy". Where ANOTHER massive ibcrease in OTCM share volumes occurred. AND where an immediate investigation SHOULD have been triggered. It did not. In fac
o was CEO of Stem Cell Therapy until 2008 https://www.sec.gov/Archives/edgar/data/1360479/000136086508000043/sciil0ksbmarch312008.txt In 2009/2010, Stem Cell Therapy did a "financing" with Prolific Bag Man Terren Peizer: Socius Form S-1 (sec.gov) EFTA00070052 Rule 424b3 Filing (sec.gov) The SEC revoked the St
2 mentions1 same-page
Page ?Same page
ltiples of the revenue generated by stand alone KCG/Knight doing "similar or less" volume. The quarter I refer to: 1Q2014. My "March 2014 letter to McKessy". Where ANOTHER massive ibcrease in OTCM share volumes occurred. AND where an immediate investigation SHOULD have been triggered. It did not. In fac
o was CEO of Stem Cell Therapy until 2008 https://www.sec.gov/Archives/edgar/data/1360479/000136086508000043/sciil0ksbmarch312008.txt In 2009/2010, Stem Cell Therapy did a "financing" with Prolific Bag Man Terren Peizer: Socius Form S-1 (sec.gov) Rule 424b3 Filing (sec.gov) The SEC revoked the Stem Cell Therapy
Sponsored
2 mentions1 same-page
Page ?Same page
ltiples of the revenue generated by stand alone KCG/Knight doing "similar or less" volume. The quarter I refer to: 1Q2014. My "March 2014 letter to McKessy". Where ANOTHER massive ibcrease in OTCM share volumes occurred. AND where an immediate investigation SHOULD have been triggered. It did not. In fac
o was CEO of Stem Cell Therapy until 2008 https://www.sec.gov/Archives/edgar/data/1360479/000136086508000043/sciil0ksbmarch312008.txt In 2009/2010, Stem Cell Therapy did a "financing" with Prolific Bag Man Terren Peizer: Socius Form S-1 (sec.gov) Rule 424b3 Filing (sec.gov) The SEC revoked the Stem Cell Therapy
Sponsored
Mutual Connections (117)
Entities connected to both McKessy and Stem Cell Therapy
CD
Chris Dilorio
PERSON337 w/ McKessy·8 w/ Stem
Jared Kushner
PERSON294 w/ McKessy·7 w/ Stem
Berger Montague
ORGANIZATION230 w/ McKessy·4 w/ Stem
J. Robert Oppenheimer
PERSON208 w/ McKessy·2 w/ Stem
CH
Carl Hoecker
PERSON199 w/ McKessy·4 w/ Stem
NO
Norberg
PERSON184 w/ McKessy·2 w/ Stem
SEC NY
ORGANIZATION127 w/ McKessy·7 w/ Stem
PE
Peizer
PERSON120 w/ McKessy·8 w/ Stem
CH
Christopher
PERSON118 w/ McKessy·6 w/ Stem
BBH AML
ORGANIZATION105 w/ McKessy·2 w/ Stem
GE
Gensler
PERSON57 w/ McKessy·7 w/ Stem
Supreme Court
ORGANIZATION52 w/ McKessy·7 w/ Stem
Casetext
ORGANIZATION35 w/ McKessy·7 w/ Stem
Samantha Power
PERSON34 w/ McKessy·8 w/ Stem
Market Statistics - Equity Trading Data
ORGANIZATION27 w/ McKessy·6 w/ Stem
PA
Pasquinelli
PERSON29 w/ McKessy·2 w/ Stem
SW
Swain
PERSON18 w/ McKessy·4 w/ Stem
George Mitchell
PERSON13 w/ McKessy·8 w/ Stem
KR
Kramer
PERSON19 w/ McKessy·2 w/ Stem
DB
Dick Best
PERSON15 w/ McKessy·2 w/ Stem